MX2021013428A - Insertos oculares polimericos disolubles y metodo de uso de los mismos. - Google Patents
Insertos oculares polimericos disolubles y metodo de uso de los mismos.Info
- Publication number
- MX2021013428A MX2021013428A MX2021013428A MX2021013428A MX2021013428A MX 2021013428 A MX2021013428 A MX 2021013428A MX 2021013428 A MX2021013428 A MX 2021013428A MX 2021013428 A MX2021013428 A MX 2021013428A MX 2021013428 A MX2021013428 A MX 2021013428A
- Authority
- MX
- Mexico
- Prior art keywords
- inserts
- eye
- same
- ocular surface
- eye inserts
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
- A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts or implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962841901P | 2019-05-02 | 2019-05-02 | |
| US201962927885P | 2019-10-30 | 2019-10-30 | |
| PCT/IB2020/054148 WO2020222195A1 (en) | 2019-05-02 | 2020-05-01 | Dissolvable polymeric eye inserts and method of using same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2021013428A true MX2021013428A (es) | 2021-12-10 |
Family
ID=70554143
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2021013428A MX2021013428A (es) | 2019-05-02 | 2020-05-01 | Insertos oculares polimericos disolubles y metodo de uso de los mismos. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US12102559B2 (https=) |
| EP (1) | EP3962450A1 (https=) |
| JP (1) | JP7350885B2 (https=) |
| KR (1) | KR20220004969A (https=) |
| CN (1) | CN113795242A (https=) |
| AU (1) | AU2020266339B2 (https=) |
| BR (1) | BR112021019774A2 (https=) |
| CA (1) | CA3137417C (https=) |
| MX (1) | MX2021013428A (https=) |
| SG (1) | SG11202110514RA (https=) |
| TW (1) | TWI826685B (https=) |
| WO (1) | WO2020222195A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11458041B2 (en) | 2015-10-08 | 2022-10-04 | Ocular Therapeutix, Inc. | Punctal plug and bioadhesives |
| US12491263B2 (en) | 2019-05-13 | 2025-12-09 | University of Pittsburgh—of the Commonwealth System of Higher Education | Polymer-based implant for retinal therapy and methods of making and using the same |
| PT3861985T (pt) | 2020-02-06 | 2023-08-03 | Ocular Therapeutix Inc | Composições e métodos para tratar doenças oculares |
| EP4142664A4 (en) | 2020-04-27 | 2024-05-29 | Ocular Therapeutix, Inc. | METHODS FOR TREATING ALLERGIC CONJUNCTIVITIS |
| US20250017769A1 (en) * | 2021-11-16 | 2025-01-16 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Polymer-based gel implant for retinal therapy and methods of making and using the same |
| TW202339703A (zh) | 2021-12-23 | 2023-10-16 | 瑞士商愛爾康公司 | 用於藥物遞送的可溶解醫療裝置 |
| TW202341919A (zh) * | 2021-12-23 | 2023-11-01 | 瑞士商愛爾康公司 | 用於角膜表面保護之可溶解醫療裝置及套件 |
| TW202339704A (zh) * | 2021-12-23 | 2023-10-16 | 瑞士商愛爾康公司 | 用於促進傷口癒合的可溶解醫療裝置 |
| WO2023214027A1 (en) * | 2022-05-06 | 2023-11-09 | Eyed Pharma | Insert for the treatment of dry eyes |
| US20240207174A1 (en) * | 2022-12-23 | 2024-06-27 | Alcon Inc. | Dissolvable polymeric eye inserts |
| WO2024180472A1 (en) * | 2023-02-28 | 2024-09-06 | Alcon Inc. | Ocular inserts |
| WO2024180453A1 (en) * | 2023-02-28 | 2024-09-06 | Alcon Inc. | Dissolvable polymeric eye inserts with a non-ionic cellulose derivative |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4730013A (en) * | 1981-10-08 | 1988-03-08 | Merck & Co., Inc. | Biosoluble ocular insert |
| PT75625B (en) * | 1981-10-08 | 1985-12-09 | Merck & Co Inc | Process for preparing biosoluble ocular insert |
| AU6107696A (en) | 1995-06-07 | 1996-12-30 | Keravision, Inc. | Radial intrastromal corneal insert and a method of insertion |
| AU2006227116A1 (en) | 2005-03-21 | 2006-09-28 | Santen Pharmaceutical Co., Ltd. | Drug delivery systems for treatment of diseases or conditions |
| AU2006330915B2 (en) | 2005-12-23 | 2011-02-03 | Intercontinental Great Brands Llc | Compositions providing a sensation substantially similar to that provided by menthol |
| ZA200904917B (en) | 2007-02-09 | 2010-09-29 | Alcon Inc | Ophthalmic compositions containing a synergistic combination of three polymers |
| US20130244978A1 (en) * | 2007-09-14 | 2013-09-19 | Rohto Pharmaceutical Co., Ltd. | Ophthalmic composition |
| US20130172357A1 (en) | 2011-02-03 | 2013-07-04 | Eye Therapies Llc | Compositions and Methods for Treatment of Glaucoma |
| US20120215184A1 (en) | 2011-02-18 | 2012-08-23 | Valeant International (Barbados) Srl | Cylindrical ocular inserts |
| US20140107025A1 (en) | 2012-04-16 | 2014-04-17 | Jade Therapeutics, Llc | Ocular drug delivery system |
| UA113434C2 (uk) * | 2012-05-04 | 2017-01-25 | Алкон Рісерч, Лтд. | Офтальмологічна композиція з поліпшеним захистом від зневоднювання й утриманням |
| RU2683651C2 (ru) | 2013-06-18 | 2019-04-01 | Иван Дмитриевич Захаров | Лекарственное средство для лечения кератоконуса и других дегенеративных заболеваний роговицы и фармацевтические препараты на его основе |
| US9782345B2 (en) | 2013-10-17 | 2017-10-10 | Jade Therapeutics, Inc. | Ocular composition and method |
| CA2947274C (en) * | 2014-04-28 | 2019-03-19 | Hampton Technologies | Ophthalmic compositions and methods for treating eyes |
| GB2541840B (en) | 2014-06-20 | 2017-09-06 | Coopervision Int Holding Co Lp | Ophthalmic composition for the treatment of ocular infection |
| US9931306B2 (en) | 2014-09-06 | 2018-04-03 | Integral Biosystems Llc | Methods and biocompatible compositions to achieve sustained drug release in the eye |
-
2020
- 2020-04-30 TW TW109114555A patent/TWI826685B/zh not_active IP Right Cessation
- 2020-05-01 CN CN202080032297.3A patent/CN113795242A/zh active Pending
- 2020-05-01 AU AU2020266339A patent/AU2020266339B2/en not_active Ceased
- 2020-05-01 EP EP20724220.7A patent/EP3962450A1/en active Pending
- 2020-05-01 MX MX2021013428A patent/MX2021013428A/es unknown
- 2020-05-01 WO PCT/IB2020/054148 patent/WO2020222195A1/en not_active Ceased
- 2020-05-01 CA CA3137417A patent/CA3137417C/en active Active
- 2020-05-01 US US16/864,894 patent/US12102559B2/en active Active
- 2020-05-01 JP JP2021561006A patent/JP7350885B2/ja active Active
- 2020-05-01 BR BR112021019774A patent/BR112021019774A2/pt not_active Application Discontinuation
- 2020-05-01 SG SG11202110514RA patent/SG11202110514RA/en unknown
- 2020-05-01 KR KR1020217033138A patent/KR20220004969A/ko not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| SG11202110514RA (en) | 2021-11-29 |
| WO2020222195A1 (en) | 2020-11-05 |
| KR20220004969A (ko) | 2022-01-12 |
| US12102559B2 (en) | 2024-10-01 |
| JP7350885B2 (ja) | 2023-09-26 |
| CA3137417C (en) | 2024-01-09 |
| TW202106286A (zh) | 2021-02-16 |
| BR112021019774A2 (pt) | 2021-12-07 |
| EP3962450A1 (en) | 2022-03-09 |
| JP2022530758A (ja) | 2022-07-01 |
| TWI826685B (zh) | 2023-12-21 |
| CA3137417A1 (en) | 2020-11-05 |
| AU2020266339A1 (en) | 2021-12-23 |
| AU2020266339B2 (en) | 2023-12-07 |
| CN113795242A (zh) | 2021-12-14 |
| US20200345544A1 (en) | 2020-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2021013428A (es) | Insertos oculares polimericos disolubles y metodo de uso de los mismos. | |
| CO2020014563A2 (es) | Uso de clorhidrato de pilocarpina para el tratamiento de condiciones oculares | |
| TW200605915A (en) | Drug delivery compositions | |
| WO2006031658A3 (en) | Therapeutic lacrimal canalicular inserts and related methods | |
| TW200603775A (en) | Anti-excitotoxic sustained release intraocular implants and related methods | |
| WO2011130462A3 (en) | Intraocular pressure reduction with intracameral bimatoprost implants | |
| WO2013030679A3 (en) | Sustained release delivery of active agents to treat glaucoma and ocular hypertension | |
| WO2016172712A3 (en) | Ophthalmic composition | |
| WO2014165308A3 (en) | Microsphere drug delivery system for sustained intraocular release | |
| HK1223271A1 (zh) | 眼部装置 | |
| WO2017158366A3 (en) | Ophthalmic delivery device and ophthalmic drug compositions | |
| EA201300272A1 (ru) | Применение фотоусиливающих агентов в ассоциации с рибофлавином, а также соответствующих офтальмологических композиций для перекрестного сшивания роговицы при лечении кератоконуса или других эктазийных расстройств роговицы | |
| MY197845A (en) | Pharmaceutical composition | |
| WO2005110367A3 (en) | Sustained release intraocular implants and methods for preventing retinal dysfunction | |
| AR073460A1 (es) | Dispositivo oftalmico con capacidad de administracion de agente terapeutico y metodo de formacion del mismo | |
| WO2008060359A3 (en) | Biodegradable ocular implants and methods for treating ocular conditions | |
| MX2019004468A (es) | Uso de lentes de contacto en el tratamiento de una afeccion oftalmologica. | |
| TW200616643A (en) | Ophthalmic compositions and methods for treating ophthalmic conditions | |
| EP4324454A3 (en) | Cross-linking agents and associated methods | |
| WO2010056598A3 (en) | Biodegradable alpha-2 adrenergic agonist polymeric implants | |
| WO2011091205A3 (en) | Intracameral sustained release therapeutic agent implants | |
| WO2009146151A3 (en) | Corneal onlay devices and methods | |
| WO2004066979A3 (en) | Sustained release device and method for ocular delivery of adrenergic agents | |
| WO2014179568A3 (en) | Two-layer ocular implant | |
| JP2011518842A5 (https=) |